IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 144 filers reported holding IMMUNOMEDICS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $3,947,000 | +624.2% | 46,400 | +21.5% | 0.19% | +419.4% |
Q4 2018 | $545,000 | -31.5% | 38,194 | 0.0% | 0.04% | +5.9% |
Q3 2018 | $796,000 | -11.9% | 38,194 | 0.0% | 0.03% | -19.0% |
Q2 2018 | $904,000 | +46.8% | 38,194 | -9.5% | 0.04% | +35.5% |
Q1 2018 | $616,000 | -78.1% | 42,194 | -75.8% | 0.03% | -77.7% |
Q4 2017 | $2,817,000 | +32.4% | 174,294 | +14.6% | 0.14% | +33.7% |
Q3 2017 | $2,128,000 | +106.2% | 152,100 | +30.2% | 0.10% | +108.0% |
Q2 2017 | $1,032,000 | +42.1% | 116,834 | +4.2% | 0.05% | +16.3% |
Q1 2017 | $726,000 | -17.6% | 112,100 | -53.3% | 0.04% | -10.4% |
Q4 2016 | $881,000 | +13.2% | 239,809 | +0.0% | 0.05% | +26.3% |
Q3 2016 | $778,000 | +11.9% | 239,710 | -20.2% | 0.04% | -19.1% |
Q2 2016 | $695,000 | +190.8% | 300,210 | +212.7% | 0.05% | +213.3% |
Q1 2016 | $239,000 | -9.5% | 96,000 | +11.6% | 0.02% | -6.2% |
Q4 2015 | $264,000 | +371.4% | 86,000 | +164.6% | 0.02% | +433.3% |
Q3 2015 | $56,000 | -57.6% | 32,500 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $132,000 | – | 32,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 4,373,178 | $371,851,000 | 55.73% |
Avoro Capital Advisors LLC | 26,250,000 | $2,232,038,000 | 31.71% |
Twin Securities, Inc. | 467,761 | $39,774,000 | 28.60% |
Palo Alto Investors LP | 4,852,383 | $412,598,000 | 22.65% |
Sand Grove Capital Management LLP | 470,000 | $39,964,000 | 21.19% |
Beryl Capital Management LLC | 1,046,632 | $88,995,000 | 16.02% |
Western Standard LLC | 158,065 | $13,440,000 | 15.26% |
One68 Global Capital, LLC | 60,990 | $5,186,000 | 13.76% |
First Light Asset Management, LLC | 1,577,880 | $134,167,000 | 13.75% |
Boxer Capital, LLC | 4,500,000 | $382,635,000 | 13.22% |